Terms: = Lung cancer AND CBFA2T3, ETO2, 863, ENSG00000129993, ZMYND4, MTGR2, MTG16 AND Prognosis
23 results:
1. Identification of molecular subtypes and a prognostic signature based on m6A/m5C/m1A-related genes in lung adenocarcinoma.
Zhang Y; Jia Q; Li F; Luo X; Wang Z; Wang X; Wang Y; Zhang Y; Li M; Bian L
Sci Rep; 2024 Mar; 14(1):7543. PubMed ID: 38555384
[TBL] [Abstract] [Full Text] [Related]
2. Prognostic implications of neutrophil-to-lymphocyte ratio in patients with extensive-stage small cell lung cancer receiving chemoimmunotherapy: A multicenter, real-world study.
Bi H; Ren D; Xiao Y; Zhou Y; Yi B; Han W; Shao Y; Wang J; Zhang C; Wang H
Thorac Cancer; 2024 Mar; 15(7):559-569. PubMed ID: 38294282
[TBL] [Abstract] [Full Text] [Related]
3. Identification of hypoxia-related gene signatures based on multi-omics analysis in lung adenocarcinoma.
Luo Q; Li X; Meng Z; Rong H; Li Y; Zhao G; Zhu H; Cen L; Liao Q
J Cell Mol Med; 2024 Jan; 28(2):e18032. PubMed ID: 38013642
[TBL] [Abstract] [Full Text] [Related]
4. Epidemiology and survival outcomes of synchronous and metachronous brain metastases: a retrospective population-based study.
Jiang K; Parker M; Materi J; Azad TD; Kamson DO; Kleinberg L; Ye X; Rincon-Torroella J; Bettegowda C
Neurosurg Focus; 2023 Aug; 55(2):E3. PubMed ID: 37527669
[TBL] [Abstract] [Full Text] [Related]
5. Prognostic Value of Pretreatment Serum Carcinoembryonic Antigen Level in 1130 Patients With Non-small Cell lung cancer: A Propensity Score Matching Cohort Study and Cumulative Meta-analysis.
Li F; Lv Q; Wang Y; Zhao S; Guo T; Wang G; Gu C
Am J Clin Oncol; 2023 Sep; 46(9):399-408. PubMed ID: 37390106
[TBL] [Abstract] [Full Text] [Related]
6. Prediction model on disease recurrence for low risk resected stage I lung adenocarcinoma.
Kwok WC; Ma TF; Ho JCM; Lam DCL; Sit KY; Ip MSM; Au TWK; Tam TCC
Respirology; 2023 Jul; 28(7):669-676. PubMed ID: 37106570
[TBL] [Abstract] [Full Text] [Related]
7. Identification of GPD1L as a Potential prognosis Biomarker and Associated with Immune Infiltrates in lung Adenocarcinoma.
Fan Z; Wu S; Sang H; Li Q; Cheng S; Zhu H
Mediators Inflamm; 2023; 2023():9162249. PubMed ID: 37035759
[TBL] [Abstract] [Full Text] [Related]
8. Improving Outcomes in NSCLC: Optimum Dose Fractionation in Radical Radiotherapy Matters.
Brada M; Forbes H; Ashley S; Fenwick J
J Thorac Oncol; 2022 Apr; 17(4):532-543. PubMed ID: 35092841
[TBL] [Abstract] [Full Text] [Related]
9. [Affinity chromatography based phosphoproteome research on lung cancer cells and its application].
Zhang B; Wang C; Guo M; Xiao H
Se Pu; 2021 Jan; 39(1):77-86. PubMed ID: 34227361
[TBL] [Abstract] [Full Text] [Related]
10. Use tumor suppressor genes as biomarkers for diagnosis of non-small cell lung cancer.
Zhang C; Jiang M; Zhou N; Hou H; Li T; Yu H; Tan YD; Zhang X
Sci Rep; 2021 Feb; 11(1):3596. PubMed ID: 33580150
[TBL] [Abstract] [Full Text] [Related]
11. A prognostic model for elderly patients with squamous non-small cell lung cancer: a population-based study.
Chen S; Gao C; Du Q; Tang L; You H; Dong Y
J Transl Med; 2020 Nov; 18(1):436. PubMed ID: 33198777
[TBL] [Abstract] [Full Text] [Related]
12. Surgical outcomes of second primary lung cancer after the extrapulmonary malignancy.
Ko KH; Huang HK; Chen YI; Chang H; Tsai WC; Huang TW
J Cancer Res Clin Oncol; 2020 Dec; 146(12):3323-3332. PubMed ID: 32632580
[TBL] [Abstract] [Full Text] [Related]
13. Second cancers in MPN: Survival analysis from an international study.
Marchetti M; Ghirardi A; Masciulli A; Carobbio A; Palandri F; Vianelli N; Rossi E; Betti S; Di Veroli A; Iurlo A; Cattaneo D; Finazzi G; Bonifacio M; Scaffidi L; Patriarca A; Rumi E; Casetti IC; Stephenson C; Guglielmelli P; Elli EM; Palova M; Rapezzi D; Erez D; Gomez M; Wille K; Perez-Encinas M; Lunghi F; Angona A; Fox ML; Beggiato E; Benevolo G; Carli G; Cacciola R; McMullin MF; Tieghi A; Recasens V; Isfort S; Pane F; De Stefano V; Griesshammer M; Alvarez-Larran A; Vannucchi AM; Rambaldi A; Barbui T
Am J Hematol; 2020 Mar; 95(3):295-301. PubMed ID: 31816122
[TBL] [Abstract] [Full Text] [Related]
14. The expression of Eps15 homology domain 1 is negatively correlated with disease-free survival and overall survival of osteosarcoma patients.
Yu H; Qu G; Wang Y; Mai W; Bao JJ; Song C; Yao M
J Orthop Surg Res; 2019 Apr; 14(1):103. PubMed ID: 30975166
[TBL] [Abstract] [Full Text] [Related]
15. Association Between Pretreatment Serum Apolipoprotein A1 and prognosis of Solid Tumors in Chinese Population: A Systematic Review and Meta-Analysis.
Wu J; Zhang C; Zhang G; Wang Y; Zhang Z; Su W; Lyu J
Cell Physiol Biochem; 2018; 51(2):575-588. PubMed ID: 30466099
[TBL] [Abstract] [Full Text] [Related]
16. Prognostic roles of lymph node micrometastasis in non-small cell lung cancer.
Jeong JH; Kim NY; Pyo JS
Pathol Res Pract; 2018 Feb; 214(2):240-244. PubMed ID: 29129492
[TBL] [Abstract] [Full Text] [Related]
17. Potential circulating miRNA signature for early detection of NSCLC.
Arab A; Karimipoor M; Irani S; Kiani A; Zeinali S; Tafsiri E; Sheikhy K
Cancer Genet; 2017 Oct; 216-217():150-158. PubMed ID: 29025589
[TBL] [Abstract] [Full Text] [Related]
18. Prognostic role of platelet to lymphocyte ratio in non-small cell lung cancers: A meta-analysis including 3,720 patients.
Zhao QT; Yuan Z; Zhang H; Zhang XP; Wang HE; Wang ZK; Duan GC
Int J Cancer; 2016 Jul; 139(1):164-70. PubMed ID: 26915723
[TBL] [Abstract] [Full Text] [Related]
19. Early Candidate Biomarkers of Non-Small Cell lung cancer Are Screened and Identified in Premalignant lung Lesions.
Nan Y; Du J; Ma L; Jiang H; Jin F; Yang S
Technol Cancer Res Treat; 2017 Feb; 16(1):66-74. PubMed ID: 26809240
[TBL] [Abstract] [Full Text] [Related]
20. Prognostic Value of 18F-FDG PET/CT in Surgical Non-Small Cell lung cancer: A Meta-Analysis.
Liu J; Dong M; Sun X; Li W; Xing L; Yu J
PLoS One; 2016; 11(1):e0146195. PubMed ID: 26727114
[TBL] [Abstract] [Full Text] [Related]
[Next]
